Peripheral
Prophylactic Inferior Vena Cava Filters Prior to Bariatric Surgery: Insights From the National Inpatient Sample

https://doi.org/10.1016/j.jcin.2019.04.011Get rights and content
Under an Elsevier user license
open archive

Abstract

Objectives

The aim of this study was to determine in-hospital mortality, post-surgical thromboembolic events, and health care costs associated with the placement of prophylactic inferior vena cava filters (IVCFs) prior to bariatric surgery.

Background

The role of prophylactic IVCFs prior to bariatric surgery is controversial, and the nationwide clinical outcomes associated with this practice are unknown.

Methods

This observational study used the National Inpatient Sample database to identify obese patients who underwent bariatric surgery from January 2005 to September 2015. Using propensity score matching, outcomes associated with patients receiving prophylactic IVCFs prior to their bariatric surgery were compared with those among patients who did not receive IVCFs.

Results

A total of 258,480 patients underwent bariatric surgery, of whom 1,047 (0.41%) had prophylactic IVCFs implanted. Patients with prophylactic IVCFs compared with those without IVCFs had a significantly higher rate of the combined endpoint of in-hospital mortality or pulmonary embolism (1.4% vs. 0.4%; odds ratio: 3.75; 95% confidence interval [CI]: 1.25 to 11.30; p = 0.019). Additionally, prophylactic IVCFs were associated with higher rates of lower extremity or caval deep vein thrombosis (1.8% vs. 0.3%; odds ratio: 6.33; 95% CI: 1.87 to 21.4; p < 0.01), length of stay (median 3 days vs. 2 days; p < 0.01), and hospital charges (median $63,000 vs. $37,000; p < 0.01).

Conclusions

In this nationwide observational study, prophylactic IVCF implantation prior to bariatric surgery was associated with worse clinical outcomes and increased health care resource utilization.

Key Words

deep vein thrombosis
inferior vena cava filters
pre-operative risk assessment
pulmonary embolism
venous thromboembolism

Abbreviations and Acronyms

CI
confidence interval
DVT
deep vein thrombosis
IQR
interquartile range
IVCF
inferior vena cava filter
LE
lower extremity
OR
odds ratio
PE
pulmonary embolism
VTE
venous thromboembolism

Cited by (0)

This study was funded by the Cardiovascular Division, Lewis Katz School of Medicine at Temple University Hospital. The sponsors had no role in the design and conduct of the study; in the collection, management, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript. Dr. Bashir has equity interest in Thrombolex. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.